Published in Blood Weekly, January 31st, 2008
"There is intense interest in the development of synthetic ligands that can intercept quorum-sensing signals and attenuate these divergent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.